Operations

i2b2 Foundation and tranSMART Foundation Merge to Become the i2b2 tranSMART Foundation

May 26, 2017

Wakefield, Massachusetts – May 25, 2017 – (Bio-IT World Conference & Expo 2017) – The tranSMART and i2b2 foundations today announce the completion of their merger to become the i2b2 tranSMART Foundation. The new organization is a global non-profit open-source foundation facilitating the further development of precision medicine and bringing it to practice.   The […]

ZS introduces AWS-powered end-to-end analytics platform for life sciences industry

May 26, 2017

EVANSTON, Ill. – May 9, 2017 – Global sales and marketing firm ZS has expanded its big data and analytics offerings with the release of an enterprise-grade, end-to-end analytics platform for the life sciences industry. REVO Analytics™ is an ecosystem of preconfigured business solutions and tools that span the entire analytics spectrum – from data […]

Akebia Therapeutics Names Rita Jain, M.D. as Chief Medical Officer

May 26, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced the appointment of Rita Jain, M.D. as Senior Vice President and Chief Medical Officer. Dr. Jain will be responsible for leading the clinical development of the Company’s […]

Optum and Merck Collaborate to Advance Value-Based Contracting of Pharmaceuticals

May 26, 2017

WAKEFIELD, Mass.–(BUSINESS WIRE)–Optum, the health services business of UnitedHealth Group (NYSE: UNH), and Merck (NYSE: MRK, known as MSD outside the U.S. and Canada), will collaborate to develop and simulate the performance of contractual reimbursement models in which payment for prescription drugs is aligned more closely with patient health outcomes. “This collaboration offers an opportunity […]

Neurana Pharmaceuticals Receives Notice of Allowance of Patents For Tolperisone, a Novel Skeletal Muscle Relaxant

May 26, 2017

SAN DIEGO, May 25, 2017 /PRNewswire/ — Neurana Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development and commercialization of products that address unmet therapeutic needs of the central nervous system, today announced receipt of a Notice of Allowance from the US Patent and Trade Office (USPTO) for two new tolperisone patents, including a […]

Merrimack Announces Management Change

May 26, 2017

CAMBRIDGE, Mass., May 25, 2017 /PRNewswire/ — Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced the resignation of Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development, effective June 9, 2017. Dr. Al-Wakeel, who has been in his role with Merrimack since August 2015, is leaving to pursue other business interests. Merrimack has […]

Aerie Pharmaceuticals Announces Public Offering of Common Stock

May 26, 2017

IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that it has commenced a registered underwritten public offering of $50 million of shares of its common stock. Cantor Fitzgerald […]

Veeva Announces Fiscal 2018 First Quarter Results

May 26, 2017

PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal first quarter ended April 30, 2017.   “Management’s Discussion and Analysis of Financial Condition and Results of Operations” Tweet this “Q1 was another great quarter across the board,” said CEO […]

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

May 26, 2017

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced that the Company is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of BRILINTA® (ticagrelor) 90mg tablets as a precautionary measure. This voluntary recall follows a report that a professional sample bottle containing eight tablets of BRILINTA 90mg also […]

Aerie Pharmaceuticals Raises $125 Million in ATM Sales and Upsized Follow-On Offering

May 26, 2017

IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that it has priced its registered underwritten public offering (the “Underwritten Offering”) of $75 million of shares of its common […]

ChromaDex Announces Closing of Second Tranche of the $25 Million Strategic Investment Led by Mr. Li Ka-shing

May 26, 2017

IRVINE, Calif., May 25, 2017 (GLOBE NEWSWIRE) — ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today the closing of the $16.4 million second tranche of the strategic investment of up to $25 […]

Jigar Raythatha Rejoins Constellation Pharmaceuticals as President and CEO

May 25, 2017

CAMBRIDGE, Massachusetts, May 25, 2017 – Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focusing on the development of novel tumor-targeted and immuno-oncology therapies based on its pioneering research in cancer epigenetics, today announced it has appointed Jigar Raythatha as president and chief executive officer. He is rejoining Constellation from Jounce Therapeutics, Inc., where he led […]

Achaogen Announces Pricing of Public Offering of Common Stock

May 25, 2017

SOUTH SAN FRANCISCO, Calif., May 25, 2017 (GLOBE NEWSWIRE) — Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $22.50 per share, for […]

Ammonett Pharma Receives Notice of Allowance of U.S. Patent for Oratrope™ Related to Detecting and Treating Growth Hormone Deficiency

May 25, 2017

MIDLOTHIAN, Va., May 25, 2017 (GLOBE NEWSWIRE) — Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue (Oratrope), today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Patent Application No: 15/271,542, entitled “DETECTING AND […]

Novartis to sever 250 U.S. workers days after announcing 500 cuts in Switzerland

May 25, 2017

Just days after announcing plans to ax 500 jobs in Switzerland, Novartis said another 250 jobs will be eliminated in the U.S., most at its headquarters in New Jersey with some of those headed to a service center in India.   The company filed a WARN notice with the state indicating that 204 jobs would […]

Medidata to Present First-of-its-kind Scientific Innovation at 2017 ASCO Annual Meeting

May 25, 2017

NEW YORK – May 17, 2017 – Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced its participation in the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, the premier cancer-focused scientific meeting.   Medidata is the first technology company ever selected by ASCO to present […]

Myopic Focus on Dashboards may Blur Insights

May 25, 2017

There is intense pressure to speed clinical trials and restrain costs, and given the burden of this duality clinical project managers are expected to make smarter decisions on intelligence derived from clinical trial data – at a faster pace, while sponsors and contract research organizations (CROs) are looking for ways to incorporate business intelligence (BI) into […]

Revive Therapeutics Ltd. Announces Results for the Three and Nine Months Ended March 31, 2017

May 25, 2017

TORONTO, ONTARIO–(Marketwired – May 25, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF) announced today its results for the three and nine months ended March 31, 2017. The unaudited condensed interim consolidated financial statements and Management’s Discussion and Analysis for the period may be viewed on SEDAR at www.sedar.com. “I am […]

Albireo Prices $45.1 Million Public Offering of Common Stock

May 24, 2017

BOSTON, May 24, 2017 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the pricing of its previously announced underwritten public offering of 2,200,000 shares of its common stock at a price to the public of $20.50 per share. Albireo’s gross proceeds from […]

TrialScope Launches Second Global Clinical Trial Disclosure Maturity Assessment

May 24, 2017

JERSEY CITY, N.J., May 24, 2017 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced the release of its second Clinical Trial Disclosure Maturity Survey for clinical trial sponsors to perform self-assessments of their disclosure practices. The measurement tool, launched in 2015, tracks clinical trial disclosure trends, clinical trial requirements […]

Publicis Health Appoints Marianne Nugent SVP/GM, CustomPoint Recruiting

May 24, 2017

Yardley, PA, May 22, 2017 — Publicis Health and Publicis Touchpoint Solutions, Inc., a leading provider of customized, omnichannel healthcare sales, service, and clinical teams, today announced Marianne Nugent as Senior Vice President and General Manager of CustomPoint Recruiting. CustomPoint Recruiting offers specialized hiring and recruiting solutions for healthcare clients; supporting their internal departments and […]

Researchers gain greater insights into experimental data by leveraging the growing collections of molecular interactions from published literature

May 24, 2017

SolveBio and Elsevier, the information analytics company, have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated pathways, with SolveBio platform, providing customers with one seamless solution to drive better precision medicine research. Under the terms of the agreement, all licensed SolveBio users will have free […]

Worldwide Clinical Trials Appoints New Vice President of Clinical Operations, Site Management

May 24, 2017

MORRISVILLE, NC, MAY 23, 2017 – Worldwide Clinical Trials (www.worldwide.com) has announced the appointment of Karen Nowatkoski as Vice President of Clinical Operations, Site Management.  The role will involve partnering closely with senior leadership across the company to support Worldwide’s business strategy and goals. Nowatkoski will oversee and provide global management for the team of […]

Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and Success

May 23, 2017

CALGARY, May 23, 2017 /PRNewswire/ – Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today highlighted two additional works involving its lead drug, apabetalone, one recently published by third party academics and one in the form of a patent application by Pfizer Inc. (Pfizer). The publication, titled “Alkaline phosphatase: a novel treatment target for cardiovascular […]

Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and Success

May 23, 2017

CALGARY, Alberta, May 23, 2017 /PRNewswire/ — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today highlighted two additional works involving its lead drug, apabetalone, one recently published by third party academics and one in the form of a patent application by Pfizer Inc. (Pfizer). The publication, titled “Alkaline phosphatase: a novel treatment target for […]

IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development

May 23, 2017

BOSTON, May 23, 2017 /PRNewswire-USNewswire/ — IFM Therapeutics (IFM), a biopharmaceutical company developing a portfolio of first-in-class small molecules targeting the innate immune system for the treatment of cancer, inflammatory and autoimmune disease, announced today that H. Martin Seidel will be joining the company as Executive Vice President of Research and Development. In this new […]

GlycoMimetics Announces Proposed Public Offering of Common Stock

May 23, 2017

ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (NASDAQ: GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced that it intends to offer and sell, subject to market conditions, 6,000,000 shares of its common stock in an underwritten public offering. All of the shares of common stock to be sold […]

Enumeral Reports First Quarter Financial Results

May 23, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM) (“Enumeral” or the “Company”), a biotechnology company focused on the discovery and advancement of next generation therapeutics in cancer and other diseases, today announced its financial results for the three months ended March 31, 2017. Recent Business Highlights In May 2017, Enumeral received an aggregate of $668,000 […]

FEEDBACK